Evidence map›Paper›PMID 23792682›Full record

ArticleAmerican journal of physiology. Heart and circulatory physiology2013

Insights into the arginine paradox: evidence against the importance of subcellular location of arginase and eNOS.

Shawn Elms, Feng Chen, Yusi Wang, Jin Qian, Bardia Askari, Yanfang Yu, Deepesh Pandey, Jennifer Iddings, Ruth B Caldwell, David J R Fulton

Abstract read
In one paragraph

Article in American journal of physiology. Heart and circulatory physiology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 78 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Subcellular Localization Guides eNOS Function.International journal of molecular sciences · 2024
    Review
  9. Review
  10. Endothelial Dysfunction in Obesity and Therapeutic Targets.Advances in experimental medicine and biology · 2024
    Review
  11. Review
  12. Albumin Is a Component of the Esterase Status of Human Blood Plasma.International journal of molecular sciences · 2023
    Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Shawn ElmsDepartment of Forensic Medicine, Nanjing Medical University, Nanjing, Jiangsu, China;
Feng Chen
Yusi Wang
Jin Qian
Bardia Askari
Yanfang Yu
Deepesh Pandey
Jennifer Iddings
Ruth B Caldwell
David J R Fulton
Augusta University Health · USUniversity of Washington · USVeterans Health Administration · US

Funding

Therapeutic Mechanisms of RhoA Inhibition In Acute Lung InjuryP01HL101902 · NHLBI · AUGUSTA UNIVERSITY · PI BLACK, STEPHEN M · 2011 to 2016
$11.2M
Metabolic Determinants of Cardiovascular Dysfunction in ObesityR01HL092446 · NHLBI · AUGUSTA UNIVERSITY · PI FULTON, DAVID J, STEPP, DAVID W · 2009 to 2013
$2.1M
Tyrosine phosphorylation of endothelial nitric oxide synthaseR01HL085827 · NHLBI · AUGUSTA UNIVERSITY · PI FULTON, DAVID J · 2007 to 2011
$1.8M
NHLBI NIH HHS P01 HL101902NHLBI NIH HHS P01-HL-101902-01A1NHLBI NIH HHS R01-HL-085827NHLBI NIH HHS R01-HL-092446
6 · The paper itself

Abstract

Reduced production of nitric oxide (NO) is one of the first indications of endothelial dysfunction and precedes overt cardiovascular disease. Increased expression of Arginase has been proposed as a mechanism to account for diminished NO production. Arginases consume l-arginine, the substrate for endothelial nitric oxide synthase (eNOS), and l-arginine depletion is thought to competitively reduce eNOS-derived NO. However, this simple relationship is complicated by the paradox that l-arginine concentrations in endothelial cells remain sufficiently high to support NO synthesis. One mechanism proposed to explain this is compartmentalization of intracellular l-arginine into distinct, poorly interchangeable pools. In the current study, we investigated this concept by targeting eNOS and Arginase to different intracellular locations within COS-7 cells and also BAEC. We found that supplemental l-arginine and l-citrulline dose-dependently increased NO production in a manner independent of the intracellular location of eNOS. Cytosolic arginase I and mitochondrial arginase II reduced eNOS activity equally regardless of where in the cell eNOS was expressed. Similarly, targeting arginase I to disparate regions of the cell did not differentially modify eNOS activity. Arginase-dependent suppression of eNOS activity was reversed by pharmacological inhibitors and absent in a catalytically inactive mutant. Arginase did not directly interact with eNOS, and the metabolic products of arginase or downstream enzymes did not contribute to eNOS inhibition. Cells expressing arginase had significantly lower levels of intracellular l-arginine and higher levels of ornithine. These results suggest that arginases inhibit eNOS activity by depletion of substrate and that the compartmentalization of l-arginine does not play a major role.

Indexed as

AnimalsAortaArginaseArginineCattleCell LineCells, CulturedChlorocebus aethiopsCitrullineCOS CellsEndothelium, VascularModels, AnimalNitric OxideNitric Oxide Synthase Type IIIOrnithineArginaseArginineCitrullineNitric OxideNitric Oxide Synthase Type IIIOrnithinearginaseendothelial nitric oxide synthasel-argininenitric oxideurea

Identifiers

PMID23792682
PMCPMC3761326
OpenAlexW2146589457

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.